Summary
The management of aneurysmal subarachnoid haemorrhage has recently changed considerably. Emergency admission to specialized centres and early surgery have become common practice. In addition, the use of nimodipine has gained widespread acceptance. Little data are available concerning the frequency and temporal profile of reruptures under the current policies.
The case histories of 387 patients treated for aneurysmal subarachnoid haemorrhage between January 1984 and March 1992 were reviewed with regard to the incidence of in-hospital reruptures. All patients were managed according to the same protocol including a policy of individually timed early surgery and intravenous nimodipine. A total of 44 first in-hospital rebleeds were observed during the waiting period. Two percent of the patients admitted on the day of haemorrhage had a rebleed on the same day after admission to the hospital. No rebleeds were observed on the day after subarachnoid haemorrhage. Rebleed rates on day 2 and 3 were also low with 0.6 and 0.8% of the population with an undipped aneurysm. For the following 10 days, the daily rate of rerupture increased. A further peak was observed during the 4th week. Using life-table methods, the cumulative rate of rebleeds was calculated as 23% within 2 weeks and 42% within 4 weeks. Although patients suffering rebleeds differed in several respects from patients without rebleeds, most of the differences could be identified to be a consequence of a selection bias resulting in a longer period of exposure to the risk of rerupture for certain subgroups. Only patients suffering a loss of consciousness after the initial subarachnoid haemorrhage were definitively exposed to a higher daily risk of rerupture.
Comparison with other series suggests that nimodipine treatment may add to the protective effect of bedrest, control of blood pressure and stress deprivation during the first days after subarachnoid haemorrhage. However, it cannot be excluded that withdrawal of nimodipine together with the general precautions in patients with unclipped aneurysms is responsible for the late peak of rebleeds. With regard to the timing of surgery, the low rebleed rates between days 1 and 3 justify semi-elective timing within this interval. On the other hand, in patients in whom aneurysm elimination has been deferred because of bad neurological condition or concomittant medical problems, surgery should be performed prior to the 4th week, unless the prognosis is considered hopeless at this time.
Similar content being viewed by others
References
Auer LM, Brandt L, Ebeling U, Gilsbach J, Gröger U, Harders A, Ljunggren B, Oppel F, Reulen HJ, Säveland H (1986) Nimodipine and early aneurysm operation in good condition SAH patients. Acta Neurochir (Wien) 82: 7–13
Aoyagi N, Hayakawa I (1984) Analysis of 223 ruptured intracranial aneurysms with special reference to rerupture. Surg Neurol 21: 445–452
Bailey I, Bell A, Gray J, Gullan R, Heikanan O, Marks PV, Marsh H, Mendelow DA, Murray G, Ohman J, Quagebeur G, Sinar J, Teasdale G, Waters A (1991) A trial of the effect of Nimodipine on outcome after head injury. Acta Neurochir (Wien) 110: 97–105
Eskesen V, Rosenorn J, Schmidt K (1988) The impact of rebleeding on the life time probabilities of different outcomes in patients with ruptured intracranial aneurysms — a theoretical evaluation. Acta Neurochir (Wien) 95: 99–101
Hashimoto N, Handa H (1983) The size of cerebral aneurysms in relation to repeated rupture. Surg Neurol 19: 107–111
Hijdra A, Vermeulen M, van Gijn J, van Crevel H (1987) Rupture of intracranial aneurysms: a clinicoanatomic study. J Neurosurg 67: 29–33
Hijdra A, van Gijn J, Nagelkerke NJD, Vermeulen M, van Crevel H (1988) Prediction of delayed cerebral ischaemia, rebleeding, and outcome after aneurysmal subarachnoid haemorrhage. Stroke 19: 1250–1255
Hillman J, von Essen C, Leszniewski W, Johansson I (1988) Significance of “ultra-early” rebleeding in subarachnoid haemorrhage. J Neurosurg 68: 901–907
Hunt WH, Kassel N, Pertuiset B, Sano K, Teasdale G, de Villier JC, Drake CG (1988) Report of the World Federation of Neurosurgical Surgeons committee on a universal subarachnoid haemorrhage grading scale. J Neurosurg 68: 985–986
Inagawa T, Kamiya K, Ogasawara H, Yano T (1987) Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol 28: 93–99
Jane J, Kassell N, Torner JC, Winn HR (1985) The natural history of aneurysms and arteriovenous malformations. J Neurosurg 62: 321–323
Juvela S (1989) Rebleeding from ruptured intracranial aneurysms. Surg Neurol 32: 323–326
Kassel NF, Torner JC (1983) Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 13: 479–481
Locksley H (1966) Report of the Cooperative Study of intracranial aneurysms and subarachnoid haemorrhage. Section V, part II, natural history of subarachnoid haemorrhage, intracranial aneurysms and arteriovenous malformations. J Neurosurg 25: 321–368
Ohman J, Heikanen O (1988) Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid haemorrhage and surgery. J Neurosurg 69: 683–686
Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, Disney LB, Khan MB, Grace M, Holness RO, Karwon MS, Ford RM, Cameron GS, Tucker WS, Purves GB, Millner JDR, Hunter KM, Richard MT, Durity FA, Chan R, Clein LJ, Maroun FB, Godon A (1988) Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68: 505–517
Pinna G, Pasqualin A, Vivenza C, Da Pian R (1988) Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study. Acta Neurochir (Wien) 93: 77–87
Rosenorn J, Eskesen V, Schmidt K, Ronde F (1987) The risk of rebleeding from ruptured intracranial aneurysms. J Neurosurg 67: 329–332
Seiler RW, Reulen HJ, Huber P, Grolimund P, Ebeling U, Steiger HJ (1988) Outcome of aneurysmal subarachnoid haemorrhage in a hospital population: a prospective study including early operation, intravenous nimodipine, and transcranial Doppler ultrasound. Neurosurgery 23: 598–604
Tomer JC, Kassell NF, Wallace RB, Adams HP (1981) Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Co-operative Aneurysm Study. Neurosurgery 9: 506–513
Torner JC, Henderson WG, Nibbelink (1981) Randomized treatment study: drug-induced hypotension. In: Sahs AL, Nibbelink DW, Torner JC (eds) Aneurysmal subarachnoid haemorrhage. Urban and Schwarzenberg, Munich, pp 77–120
Vermeulen M, van Gijn J, Hijdra A, van Crevel H (1984) Causes of acute deterioration in patients with a ruptured intracranial aneurysm: a prospective study with serial CT scanning. J Neurosurg 60: 935–939
Winn HR, Almaani WS, Berga SL, Jane JA, Richardson AE (1983) The long-term outcome in patients with multiple aneurysms. J Neurosurg 59: 642–651
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steiger, H.J., Fritschi, J. & Seiler, R.W. Current pattern of in-hospital aneurysmal rebleeds. Acta neurochir 127, 21–26 (1994). https://doi.org/10.1007/BF01808541
Issue Date:
DOI: https://doi.org/10.1007/BF01808541